Cardinal Health Inc (CAH) is Initiated by Avondale to Mkt Outperform, Price Target at $111

Cardinal Health Inc (CAH) was Initiated by Avondale to “Mkt Outperform” and the brokerage firm has set the Price Target at $111. Avondale advised their investors in a research report released on Apr 19, 2016.

Many Wall Street Analysts have commented on Cardinal Health Inc. Cardinal Health Inc was Initiated by Credit Suisse to “Outperform” on Mar 16, 2016. Shares were Reiterated by RBC Capital Mkts on Feb 11, 2016 to “Outperform” and Lowered the Price Target to $ 95 from a previous price target of $105 .

On the company’s financial health, Cardinal Health Inc reported $1.30 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Feb 1, 2016. Analyst had a consensus of $1.26. The company had revenue of $31445.00 million for the quarter, compared to analysts expectations of $29227.04 million. The company’s revenue was up 23.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.20 EPS.

Cardinal Health Inc opened for trading at $83.79 and hit $84.64 on the upside on Monday, eventually ending the session at $84.57, with a gain of 0.38% or 0.32 points. The heightened volatility saw the trading volume jump to 9,46,655 shares. Company has a market cap of $27,851 M.

In a different news, on Nov 12, 2015, George S Barrett (Chairman and CEO) sold 54,658 shares at $87.73 per share price. According to the SEC, on Nov 9, 2015, Falk T Stephen (EVP, Gen. Counsel & Corp. Sec.) sold 30,085 shares at $87.66 per share price. On Aug 7, 2015, David J Anderson (director) purchased 1,400 shares at $86.41 per share price, according to the Form-4 filing with the securities and exchange commission.

Cardinal Health Inc. is a healthcare services and products company. The Company operates in two segments: Pharmaceutical and Medical. The Company also provides medical products to patients in the home. In the United States the Company’s Pharmaceutical segment distributes branded and generic pharmaceutical over-the-counter healthcare and consumer products through its Pharmaceutical Distribution division to retailers hospitals and other healthcare providers. In China the Pharmaceutical segment distributes branded generic and specialty pharmaceutical over-the-counter healthcare and consumer products provides logistics marketing and other services and operates direct-to-patient specialty pharmacies through Cardinal Health China. The Medical segment distributes a range of medical surgical and laboratory products and provides services to hospitals ambulatory surgery centers clinical laboratories and other healthcare providers.

Cardinal Health Inc

Leave a Reply

Cardinal Health Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Cardinal Health Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.